Administer by intravenous infusion over 60 minutes. Do not administer as a rapid bolus injection. Reconstitute the powder with sterile water for injection, then dilute in appropriate intravenous fluid.

Lemulicin selectively binds to a unique ribosomal subunit, thereby inhibiting bacterial protein synthesis crucial for bacterial growth and survival. This leads to bactericidal activity against a wide range of gram-positive and gram-negative bacteria.

• •Known hypersensitivity to Lemulicin or any components of the formulation.
• •Severe hepatic impairment.

Store below 25°C. Protect from light. Do not freeze. Keep out of reach of children. Reconstituted solution should be used immediately.

In case of overdose, symptomatic and supportive measures should be taken. Hemodialysis may be considered, although specific data on its effectiveness in removing Lemulicin are limited.

Pregnancy Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution should be exercised when administered to a nursing woman as Lemulicin is excreted in breast milk.